FORESEE PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.3 TWD | +0.53% |
|
-1.77% | -1.98% |
Chart calendar Foresee Pharmaceuticals Co., Ltd.
a62dc7a67c5.So4ip6ZuroXoR6pTJn4tA3JRDzSk3rLNsxaZFW-3Ovo.K98WivkC--imA-EhUDoZbSA5PVnqnYei_FqsJ1mCe5V97A_Vyxvc7Jgd5w~12d5247cefa46d89b6d260398091ea55
Upcoming events on Foresee Pharmaceuticals Co., Ltd.
Past events on Foresee Pharmaceuticals Co., Ltd.
| Today | Q1 2024 Earnings Release (Projected) |
| 10/04/2024 03:53 pm | March 2024 Sales and Revenue Release |
| 15/03/2024 | Q4 2023 Earnings Release |
| 08/03/2024 03:10 pm | February 2024 Sales and Revenue Release |
| 07/02/2024 01:47 pm | January 2024 Sales and Revenue Release |
| 08/01/2024 03:53 pm | December 2023 Sales and Revenue Release |
| 21/12/2023 12:00 pm | KGI Securities Investor Conference |
| 08/12/2023 03:38 pm | November 2023 Sales and Revenue Release |
| 11/11/2023 09:45 pm | American Heart Association Scientific Meeting |
| 10/11/2023 02:41 pm | Q3 2023 Earnings Release |
| 08/11/2023 03:22 pm | October 2023 Sales and Revenue Release |
| 11/10/2023 12:02 pm | September 2023 Sales and Revenue Release |
| 30/09/2023 08:40 am | Fanconi Anemia Research Fund Scientific Symposium |
| 11/09/2023 01:00 pm | European Respiratory Society International Congress |
| 08/09/2023 04:08 pm | August 2023 Sales and Revenue Release |
| 14/08/2023 01:47 pm | Q2 2023 Earnings Release |
| 09/08/2023 04:41 pm | July 2023 Sales and Revenue Release |
| 10/07/2023 12:00 pm | KGI Securities Investor Conference |
| 07/07/2023 03:20 pm | June 2023 Sales and Revenue Release |
| 20/06/2023 07:02 pm | WASOG International Conference - Poster No : 4998-A-2326 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 75,2 75,0 0.26% | 230 230 0.19% | 226 226 0.01% | 302 366 -17.62% | 195 195 0.02% | 916 |
|
EBITDA Million TWD | Released Forecast Spread | -431 -620 30.5% | -435 -400 -8.83% | -487 -473 -3.06% | -418 -550 23.95% | -958 -852 -12.47% | 6,00 |
|
EBIT Million TWD | Released Forecast Spread | -470 -639 26.37% | -485 -405 -19.85% | -539 -526 -2.47% | -469 -597 21.37% | -1 024 -932 -9.84% | -85,0 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -470 -637 26.16% | -483 -403 -19.95% | -528 -509 -3.83% | -438 -570 23.14% | -996 -897 -11.04% | -76,0 |
|
Net income Million TWD | Released Forecast Spread | -487 -654 25.45% | -511 -410 -24.56% | -569 -558 -1.97% | -473 -597 20.83% | -1 036 -937 -10.6% | -76,0 |
|
EPS TWD | Released Forecast Spread | -5,08 -6,61 23.09% | -5,04 -3,81 -32.28% | -4,85 -4,72 -2.68% | -4,00 -5,06 20.95% | -8,14 -7,93 -2.65% | -0,64 |
| Announcement Date | 24/03/20 | 24/03/21 | 25/03/22 | 24/02/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,45 0,00 - | 67,0 0,00 - | 207 209 -1.12% | 18,1 27,0 -32.94% | 9,76 65,0 -84.99% | 28,4 95,3 -70.2% | 37,5 55,5 -32.46% | 60,7 73,5 -17.38% | 68,4 68,0 0.62% | 116 | 121 | 548 | 131 |
|
EBITDA Million TWD | Released Forecast Spread | -181 -168 -7.45% | -108 -121 10.64% | 42,4 98,0 -56.75% | -156 -82,0 -90.82% | -256 -134 -90.97% | -223 -121 -84.45% | -323 -217 -48.72% | -103 | -103 | 315 | -103 | ||
|
EBIT Million TWD | Released Forecast Spread | -193 -180 -7.05% | -120 -195 38.3% | 30,7 8,00 283.6% | -175 -187 6.17% | -204 -321 36.34% | -174 -132 -32.23% | -274 -151 -81.16% | -242 -135 -79.76% | -335 -243 -37.65% | -126 | -126 | 292 | -125 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -193 -179 -7.59% | -116 -192 39.55% | 42,4 4,00 960.5% | -160 -176 8.93% | -204 -321 36.39% | -173 -130 -33% | -269 -151 -78.25% | -216 -132 -64.14% | -338 -239 -41.48% | -123 | -123 | 294 | -125 |
|
Net income Million TWD | Released Forecast Spread | -193 -179 -7.95% | -122 -192 36.3% | 21,8 4,00 445.08% | -164 -176 6.77% | -208 -321 35.19% | -179 -126 -42.83% | -282 -146 -93.77% | -237 -128 -85.53% | -339 -239 -41.66% | -123 | -123 | 294 | -125 |
|
EPS TWD | Released Forecast Spread | -1,64 -1,52 -7.66% | -1,04 -1,63 36.2% | 0,18 0,03 500% | -1,39 -1,49 6.71% | -1,76 -2,72 35.29% | -1,52 -1,07 -42.72% | -2,37 -1,16 -104.31% | -1,74 -1,02 -70.59% | -2,53 -2,02 -25.25% | -1,04 | -1,04 | 2,49 | -1,05 |
| Announcement Date | 25/03/22 | 13/05/22 | 10/08/22 | 11/11/22 | 24/02/23 | 15/05/23 | 14/08/23 | 10/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Foresee Pharmaceuticals Co., Ltd.
| Today | HUMACYTE, INC.: Q1 2024 Earnings Release |
| Today | NOVAVAX, INC.: Q1 2024 Earnings Release |
| Today | TAKARA BIO INC.: Q4 2023 Earnings Release |
| Today | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:35 am | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | OMNIAB, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 05:30 pm | CG ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 09/05/2024 05:30 pm | DISC MEDICINE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 05:30 pm | VERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6576 Stock
- Calendar Foresee Pharmaceuticals Co., Ltd.